Final Program [International Conference on AIDS (14th: 2002: Barcelona, Spain)]

Poster Exhibitions

Thursday July ii

Poste ExhibitionsIThursda jl -i

ThPeB73o5 Safety and immunogenicity of recombinant outer
surface Protein-A Lyme Vaccine in HIV infected
patients: evaluation of a 3-dose schedule at o, 1,
and 2 months
M Henry, ] Handel, R Holzman, ] Greene
(United States)
ThPeB73o6 CIN is an important biological risk marker in HIV
infected women
VAcharya, D Mathur, N Vyas, S Mehta (India)
ThPeB73o7 Epstein-Barr Virus (EBV) and proviral HIV DNA
quantification in HIV+ patients under highly
active antiretroviral therapy (HAART)
CAmiel, CDutreuil, VSchneider, CLependeven,
W Rozenbaum, ] C Nicolas (France)
ThPeB73o8 High HPV viral loads associated with advanced
immunodeficiency and pre-invasive cervical
lesions in HIV infected women in Rio de Janeiro
(RJ), Brazil (BR)
B Grinszten, F I Bastos, V G Veloso, F Russomano,
M Morgado, ] H Pilotto, R K Friedman, E Taromaru,
M Derrico, M Schechter (Brazil)
ThPeB73o9 Does HAART have an effect on genital HPV DNA
virus load in HIV-infected women?
L J Conley, TJ Bush, TV Ellerbrock, ] L Lennox,
F Wu, T Evans-Strickfaden, CE Hart, T C Wright
(United States)
ThPeB731o HIV-related Malignancies in the HAART era
I E Salit P Chantler (Canada)
ThPeB7311 stanford v regimen and highly active antiretroviral
therapy (HAART) in patients (pts) with HD and
HIV infection (HD-HIV)
M Spina', ] Gabarre2, A Mainini, A Re', E Vaccher',
U Tirelli (ltaly; 2France)
ThPeB7312 Invasive cervical cancer in women with and
without AIDS in 15 European countries
D Serraino', L Dal Masol, P Pisellil, C La Vecchia',
S Franceschi2 1taly; 2France)
ThPeB7313 Multicentre cohort study of testicular cancer in
men with HIV
TPowles M Nelson, T Oliver, M Fisher, ] Stebbing,
M] Johnson, B G Gazzard, M Bower (United Kingdom)
ThPeB7314 Vaginal shedding of HHV8 is rare in women with
HIV infection
D Serraino M Capobianchi, G Ippolito, P Piselli,
M Peroni, F Carletti, C Pavia, G Nurra, S Zaniratti,
CAngeletti, S Calcaterra, G Rezza (Italy)
ThPeB7315 Favorable impact of HAART on response to
therapy and survival in patients with AIDS-related
Hodgkins's disease (ARHD)
IM Ribera, ] T Navarro, A Oriol, A LopezGuillermo, E Abella, ] A Hernandez-Rivas,
A Sureda, E Feliu (Spain)
ThPeB7316 Risk factors for Cervical Squamous Intraepithelial
Thursday Lesions in HIV-1 positive women in Porto Alegre -
Brazil
R Kreitchmann (Brazil)
ThPeB7317 High Dose Therapy and Autologous Peripheral
Blood Stem Cell (PBSC) Transplantation in Pts.
with HIV-Associated Lymphoma Refractory to or
Relapsed after First-Line Chemotherapy
CS Casari S, R G Rossi G2, R A Re Alessandro2,
T U Tirelli U2, MF Moretti P, Q E Quiros-Roldan
E2, C G P Cadeo GP2, C G Carosi G2, F P Ferremi P2,
LA Lanfranchi A2, T L Tomasoni L2, A M Airoldi M2,
T C Torti C2, P G Paraninfo 62, CA Chiodera A2,
M P Milini P2, C G Cristini G2 (lKazakhstan; 2Italy)

ThPeB7318 HIV-related lymphoma: Rituximab concomitant to
second-line chemotherapy following tumor
progression under CHOP or early relapse
L G Goelkel, R Weiss, P Kreckel (Germany)
ThPeB7319 Effect of ritonavir-boosted protease inhibitor (PI)
regimens on lipid profiles
GA McComsey, A Chu (United States)
ThPeB732o No difference in association between individual
thymidine analogues and HIV-associated
lipodystrophy in an ambulatory population
The LION-HAART-Cohort
E Lauenroth-Mai, FSchlote (Germany)
ThPeB7321 Lipoprotein patterns associated with
antiretroviral therapy indicate a low
cardiovascular risk
S Mauss, ] Stechel, G Schmutz, F Berger,
W 0 Richter (Germany)
ThPeB7322 A randomised open label study of 3 substitution
strategies in hypercholesterolemic persons
virologically controlled on first line antiretroviral
therapy (ART)
G jMoyle, C Baldwin, B G Gazzard (United Kingdom)
ThPeB7323 Zinc intake and mortality in HIV-l infected drug
users
M K Baum, A Campa, S Lai, H Lai, Z Yang, S Sales,
K King, B Page (United States)
ThPeB7324 Effects of HIV protease inhibitors on the
differentiation of the 3T3 442A adipocyte cell line
N Parassol, ZAmri, C Le Saint, ] P Vincent, A Cupo
(France)
ThPeB7325 Lipid Profile of untreated HIV positive men who
have sex with men
B Baza Caraciolo ] Sdnchez Alonso, D Carrid
Montiel, S del Corral del Campo, A Quintana
Molina, M Heredero Sebastidn, S Garcfa Pdrez,
] del Romero Guerrero (Spain)
ThPeB7326 Safety and tolerability of lopinavir/ritonavir (ABT378/r) during the early access program (EAP) in a
center from Buenos Aires
N Porteiro H Mingrone, L Rd, E Loiza (Argentina)
ThPeB7327 The ratio of visceral/subcutaneous adipose
tissue (VAT/SAT) has different implications in
naive patients and patients on protease inhibitor
containing highly active antiretroviral treatment
(PI-ART)
K Koppel, G Bratt, H Bylund, B Lund,
EL Fredriksson, E Sandstrdm (Sweden)
ThPeB7328 The effect of gender and race on central adiposity
and hyperlipidaemia in a group of HIV positive
people taking HAART
V Pribram (United Kingdom)
ThPeB7329 The association between weight loss and survival
in HIV-positive patients in the era of highly active
antiretroviral therapy
A M Tang, ] Forrester, D Spiegelman, TA Knox,
E Tchetgen, S L Gorbach (United States)
ThPeB733o Factors associated with decreased bone mineral
density in HIV-positive women
D Peabody E Mann, D Burdge, T Rempel, ] Prior,
C Morris (Canada)
ThPeB7331 Body composition assessment of HIV-associated
lipodystrophy
W L Dinges, D Chen, A Agyarko, P Weatherall,
D M Peterson, A Garg (United States)
ThPeB7332 Predictors of adherence to antiretroviral therapy
in an inner city population

S Mannheimer, M Perkins, B Diamond, ] Ford,
N Holson, S Findley, P Colson, W El-Sadr
(United States)

224 Final Program